TELO · Telomir Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Aminov Erez Chief Executive Officer | ▼ Sell | Other | 7,319,710 Shares held | 4/22/2026 | View profile |
| Bay Shore Trust | ▲ Buy | Open Market | 1,902,659 Shares held | 2/13/2024 | View profile |
Transaction History
| Aminov Erez | ▼ Sell | Other | 7,319,710 | $10.0M | 4/22/2026 |
| Bay Shore Trust | ▲ Buy | Open Market | 49,000 | $343K | 2/13/2024 |
| Bay Shore Trust | ▲ Buy | Open Market | 49,000 | $343K | 2/13/2024 |
| Bay Shore Trust | ▲ Buy | Open Market | 40,000 | $280K | 2/13/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Telomir Raises ~$5.6M via PIPE Financing
Telomir Pharmaceuticals announced it will raise about $5.6 million by issuing new common shares in a private placement. The capital will support the company’s research and development efforts, potentially helping to advance its drug pipeline. The share issuance may increase the number of shares outstanding, which could affect the stock price and dilution.
Telomir Raises ~$5.6M via PIPE Financing. Telomir Pharmaceuticals announced it will raise about $5.6 million by issuing new common shares in a private placement. The capital will support the company’s research and development efforts, potentially helping to advance its drug pipeline. The share issuance may increase the number of shares outstanding, which could affect the stock price and dilution.